Sarah Kiehna is a Director of Analytical Development and Quality Control at AbbVie, with a Ph. D. from The University of North Carolina at Chapel Hill. Her career has progressed from peptide chemistry to leading roles in biologics and biosimilars, including significant contributions to regulatory submissions at Pfizer and Hospira.
Sarah is passionate about defeating life-changing diseases like cancer and is actively building a team of talented scientists to develop future biologic therapies. Her focus is on combining people and passion to explore new possibilities in treatment.
During her time at Pfizer, she was a key contributor to the bioanalytical assessments for the FDA-approved biosimilar drug, NIVESTYM.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.